Jay R. Luly
Overview
Jay R. Luly received an average of $4M in total compensation, including $560K in salary, at Enanta Pharmaceuticals from 2011 to 2022.
2022Enanta PharmaceuticalsPresident and Chief Executive Officer
2021Enanta PharmaceuticalsPresident and Chief Executive Officer
2020Enanta PharmaceuticalsPresident and Chief Executive Officer
2019Enanta PharmaceuticalsPresident and Chief Executive Officer
2018Enanta PharmaceuticalsPresident and Chief Executive Officer
2017Enanta PharmaceuticalsPresident and Chief Executive Officer
2016Enanta PharmaceuticalsPresident and Chief Executive Officer
2015Enanta PharmaceuticalsPresident and Chief Executive Officer
2014Enanta PharmaceuticalsPresident and Chief Executive Officer
2013Enanta PharmaceuticalsPresident and Chief Executive Officer
Source: SEC filings on January 20, 2023, January 21, 2022, January 21, 2021, January 17, 2020, January 18, 2019, January 19, 2018, January 6, 2017, January 13, 2016, January 15, 2015, and January 10, 2014.
Related executives
We found seven more executives who work or worked at Enanta Pharmaceuticals.
Scott Rottinghaus
Enanta Pharmaceuticals
Chief Medical Officer
Yat Or
Enanta Pharmaceuticals
Chief Scientific Officer
Nathaniel Gardiner
Enanta Pharmaceuticals
General Counsel
Paul Mellett
Enanta Pharmaceuticals
Chief Financial Officer
Brendan Luu
Enanta Pharmaceuticals
Senior Vice President, Business Development
Tara Kieffer
Enanta Pharmaceuticals
Senior Vice President, New Product Strategy & Development
Nathalie Adda
Enanta Pharmaceuticals
Chief Medical Officer
News
Enanta Pharmaceuticals CEO Jay Luly's 2022 pay jumps 37% to $7.3M
January 20, 2023
Enanta Pharmaceuticals CEO Jay Luly's 2021 pay rises 2% to $5.3M
January 21, 2022
Enanta Pharmaceuticals CEO Jay Luly's 2020 pay rises 16% to $5.2M
January 21, 2021
Enanta Pharmaceuticals CEO Jay Luly's 2019 pay slips 1% to $4.5M
January 17, 2020
Enanta Pharmaceuticals CEO Jay Luly's 2018 pay rises 5% to $4.5M
January 18, 2019